Nunzia Pharmaceutical (NUNZ) Financial Statements
Nunzia Pharmaceutical Financial Overview
Nunzia Pharmaceutical's market cap is currently $43.46K. The company's EPS TTM is $-0.31; its P/E ratio is 0.00; Nunzia Pharmaceutical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -78.06M | $ -39.33K | $ -33.63K | $ -27.17K | $ -13.04K |
| EBITDA | $ 0.00 | $ -9.04M | $ 0.00 | $ 5.39K | $ 0.00 |
| Net Income | $ -78.06M | $ -101.02M | $ -33.63K | $ -18.58K | $ -13.04K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 131.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Total Assets | $ 5.13K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Total Debt | $ 97.44K | $ 23.00K | $ 0.00 | $ 23.00K | $ 23.00K |
| Net Debt | $ -34.00 | $ 23.00K | $ 0.00 | $ 23.00K | $ 23.00K |
| Total Liabilities | $ 99.31K | $ 36.40K | $ 22.57K | $ 293.97K | $ 275.39K |
| Stockholders' Equity | $ -94.17K | $ -59.40K | $ -22.57K | $ -293.97K | $ -275.39K |
| Cash Flow | |||||
| Free Cash Flow | $ -86.78K | $ -9.00M | $ -3.80K | $ 0.00 | $ 0.00 |
| Operating Cash Flow | $ -86.78K | $ -9.00M | $ -3.80K | $ 0.00 | $ 0.00 |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 86.91K | $ 2.50K | $ 3.80K | $ 0.00 | $ 0.00 |
Currency in USD